Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE‐CIDP 3 trial.
Saved in:
| Title: | Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE‐CIDP 3 trial. |
|---|---|
| Authors: | Hadden, Robert D. M.1,2, Andersen, Henning3, Bril, Vera4, Basta, Ivana5, Rejdak, Konrad6, Duff, Kim7, Greco, Erin7, Hasan, Shabbir7, Anderson‐Smits, Colin7, Ay, Hakan7 hakan.ay@takeda.com |
| Source: | Journal of the Peripheral Nervous System. Dec2024, Vol. 29 Issue 4, p441-452. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10859489 |
|---|---|
| DOI: | 10.1111/jns.12672 |
